Mature T-cell leukemia/lymphoma cells can release EVs containing miRNA-21, miRNA-155 and vascular endothelial growth factor (VEGF), inducing NF-κB activation, resulting in changing of cellular morphology and increasing of proliferation, migration and angiogenic markers in recipient mesenchymal stem cells [25]. The gene discussed is VEGFA; the disease is lymphoma.